Rochat B. | Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
スポンサーリンク
概要
- ROCHAT B.の詳細を見る
- 同名の論文著者
- Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univの論文著者
関連著者
-
Rochat B.
Plate-forme De Spectrometrie De Masse Department De Recherche Centre Hospitalier Universitaire Vaudo
-
Decosterd L.
Division Of Clinical Pharmacology Department Of Internal Medicine Bh 18-lab 218 Centre Hospitalier U
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Rochat B.
Quantitative Mass Spectrometry Facility Of The Chromatography-mass Spectrometry Platform Of The Univ
-
Decosterd L.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
ZANOLARI B.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
Zanolari B.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Zanolari B.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Widmer N.
Division De Pharmacologie Clinique Laboratoire Bh 18-218 Department De Medicine Centre Hospitalier U
-
Buclin T.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Beguin A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Leyvraz S.
Pluridisciplinary Cancer Center Centre Hospitalier Universitaire Vaudois
-
Duchosal M.
Service D'hematologie Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Biollaz J.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois
-
Guignard N.
Division De Pharmacologie Clinique Department De Medicine Laboratoire Bh 18-218 Centre Hospitalier U
-
Zaman K.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Leyvraz S.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Telenti A.
Institute Of Microbiology University Hospital Of Lausanne
-
HAOUALA A.
Division de Pharmacologie clinique, Department de Medicine, Centre Hospitalier Universitaire Vaudois
-
MONTEMURRO M.
Multidisciplinary Oncology Centre, Centre Hospitalier Universitaire Vaudois and University of Lausan
-
RIS H.
Divisions of Thoracic and Vascular Surgery, Centre Hospitalier Universitaire Vaudois and University
-
FAYET A.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
CRUCHON S.
Division of Clinical Pharmacology and Toxicology, University Hospital of Lausanne
-
CAVASSINI M.
Service of Infectious Diseases, University Hospital of Lausanne
-
GUNTHARD H.
Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich
-
Ris H.
Divisions Of Thoracic And Vascular Surgery Centre Hospitalier Universitaire Vaudois And University O
-
Haouala A.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
-
Montemurro M.
Multidisciplinary Oncology Centre Centre Hospitalier Universitaire Vaudois And University Of Lausann
-
Cavassini M.
Service Of Infectious Diseases University Hospital Of Lausanne
-
Cruchon S.
Division Of Clinical Pharmacology And Toxicology Department Of Medicine Lausanne Centre Hospitalier
-
Fayet A.
Division Of Clinical Pharmacology And Toxicology University Hospital Of Lausanne
-
Gunthard H.
Division Of Infectious Diseases And Hospital Epidemiology University Hospital Zurich
-
Widmer N.
Division De Pharmacologie Clinique Department De Medicine Centre Hospitalier Universitaire Vaudois A
著作論文
- Therapeutic Drug Monitoring of the new targeted anticancer agents imatinib, nilotinib, dasatinib, sunitinib, sorafenib and lapatinib by LC tandem mass spectrometry
- A LC-tandem MS assay for the simultaneous measurement of new antiretroviral agents : Raltegravir, maraviroc, darunavir, and etravirine